KalVista Pharmaceuticals
KALV
KALV
82 hedge funds and large institutions have $303M invested in KalVista Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
82
Holders Change
+19
Holders Change %
+30.16%
% of All Funds
1.45%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
23
Increased
22
Reduced
24
Closed
4
Calls
$5.6M
Puts
$6.68M
Net Calls
-$1.08M
Net Calls Change
-$1.08M
Top Buyers
1 |
BlackRock
New York
|
+$3.77M |
2 |
LGM
Logos Global Management
San Francisco,
California
|
+$3.61M |
3 |
![]()
Franklin Resources
San Mateo,
California
|
+$3.15M |
4 |
VC
Vivo Capital
Palo Alto,
California
|
+$2.69M |
5 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.06M |
Top Sellers
1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$3.26M |
2 |
GTC
Ghost Tree Capital
New York
|
-$2.85M |
3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$2.62M |
4 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$1.92M |
5 |
![]()
Adage Capital Partners
Boston,
Massachusetts
|
-$1.9M |